JOHNSON & JOHNSON Long-Term Concentrated

Location: New Brunswick, NJ

CIK: 0000200406 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 2, 2023

Total Value: $322M (100.0% shares, 0.0% debt)

Holdings (22)

PTGX Protagonist Therapeutics Inc. 21.0%
Value $67.65M Shares 2,449,183 Est. Cost $42.63 Unrealized -41.3%
LEGN Legend Biotech Corporation 17.5%
Value $56.23M Shares 814,586 Est. Cost $50.56 Unrealized
CVRX CVRx, Inc. 16.8%
Value $53.97M Shares 3,495,575 Est. Cost $19.18 Unrealized -36.4%
MGTX MeiraGTx Holdings plc 13.9%
Value $44.63M Shares 6,641,064 Est. Cost $9.84 Unrealized -34.6%
XNCR Xencor, Inc. 5.8%
Value $18.68M Shares 748,062 Est. Cost $37.91 Unrealized -28.2%
Fusion Pharmaceuticals Inc. 5.3%
Value $17.14M Shares 3,670,516 Est. Cost $7.92 Unrealized
FATE Fate Therapeutics, Inc. 5.0%
Value $16.08M Shares 3,379,064 Est. Cost $78.44 Unrealized -93.0%
PRCT Procept BioRobotics Corporation 3.9%
Value $12.65M Shares 357,939 Est. Cost $38.38 Unrealized -13.9%
Point Biopharma Global Inc. 2.8%
Value $9.06M Shares 1,000,000 Est. Cost $7.69 Unrealized
ARWR Arrowhead Pharmaceuticals, Inc. 2.7%
Value $8.829M Shares 247,598 Est. Cost $64.75 Unrealized -46.7%
NNOX Nano-X Imaging Ltd. 1.5%
Value $4.921M Shares 317,704 Est. Cost $15.61 Unrealized -11.2%
Vor Biopharma, Inc. 1.0%
Value $3.321M Shares 1,074,658 Est. Cost $15.68 Unrealized
ALDX Aldeyra Therapeutics, Inc. 1.0%
Value $3.313M Shares 394,834 Est. Cost $9.18 Unrealized +7.4%
HLTHQ Cue Health, Inc. 0.6%
Value $2.048M Shares 5,548,864 Est. Cost $11.81 Unrealized
Adicet Bio, Inc. 0.5%
Value $1.771M Shares 728,944 Est. Cost $7.84 Unrealized
BiomX Inc. 0.2%
Value $768K Shares 2,133,402 Est. Cost $3.06 Unrealized
SomaLogic, Inc. 0.2%
Value $649K Shares 281,052 Est. Cost $12.39 Unrealized
Clearside Biomedical, Inc. 0.1%
Value $190K Shares 169,629 Est. Cost $1.12 Unrealized
Apollomics, Inc. 0.0%
Value $75,934 Shares 13,252 Est. Cost $24.20 Unrealized
Senseonics Holdings, Inc. 0.0%
Value $41,681 Shares 54,621 Est. Cost $3.39 Unrealized
Tracon Pharmaceuticals, Inc. 0.0%
Value $24,445 Shares 84,003 Est. Cost $3.87 Unrealized
Catalyst Biosciences, Inc. 0.0%
Value $23,540 Shares 66,951 Est. Cost $4.11 Unrealized